<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02976792</url>
  </required_header>
  <id_info>
    <org_study_id>DC 2016/94</org_study_id>
    <nct_id>NCT02976792</nct_id>
  </id_info>
  <brief_title>Effectiveness of the NephroCheck™ After TAVI</brief_title>
  <acronym>AKI-TAVI</acronym>
  <official_title>Effectiveness of the NephroCheck™ to Predict Postoperative Acute Kidney Injury in Patients Undergoing a Transcatheter Aortic Valve Implantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Bordeaux</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Bordeaux</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Postoperative acute renal failure is a frequent complication after a Transcatheter Aortic
      Valve Implantation (TAVI). The current practice cannot predict Acute Kidney Injuries (AKI)
      early enough to prevent an organic dysfunction triggering, consequently, cortical tubular
      necrosis.

      Several recent studies in cardiac surgery have shown that sonographic criteria, the Renal
      Resistive Index (IRR), and a urinary biomarker, the NephroCheck™, could predict AKI promptly.
      These markers, sonographic and biologic, have both the advantage to be non-invasive and easy
      to perform. Each marker seems to have sensitivity and specificity to predict AKI promptly
      after cardiac surgery. Therefore, the IRR and the NephroCheck™ test could become essential
      tests to guide clinicians in determining rapidly whether a patient will develop AKI after a
      TAVI procedure. However, so far, no study has tested the NephroCheck™ in patients undergoing
      TAVI.

      Therefore, the aim of this prospective observational study will be first to determine the
      effectiveness of the NephroCheck™ to predict AKI at an early stage after a TAVI procedure.
      The secondary outcome will be to compare the NephroCheck™ with the RRI in predicting at an
      earlier stage than the traditional method an AKI.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">March 2018</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Effectiveness of the NephroCheck™ test to detect AKI after TAVI</measure>
    <time_frame>Evolution of the Nephrocheck test from the time 0 to time 2.(Time 0: at inclusion before the TAVI / Time 1: NephroCheck™ Test at the first micturition post TAVI / Time 2: NephroCheck test™ on the first post operative day at the first micturition.)</time_frame>
    <description>Determine the efficacy of NephroCheck™ test to predict AKI after TAVI. AKI will be defined according to the KADIGO criteria.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Renal Resistive Index compared with NephroCheck™</measure>
    <time_frame>Evolution of the Renal Resistive Index from time 0 to time 2. Time 0: at inclusion before the TAVI / Time 1: at the first micturition post TAVI/ Time 2: on the first post operative day at the first micturition.</time_frame>
    <description>compare the NephroCheck™ with the Renal Resistive Index in predicting an AKI</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">125</enrollment>
  <condition>Transcatheter Aortic Valve Implantation</condition>
  <condition>Acute Kidney Injury</condition>
  <condition>Postoperative Acute Renal Failure</condition>
  <arm_group>
    <arm_group_label>Renal Resistive Index/NephroCheck™test</arm_group_label>
    <description>Patients undergoing a transcatheter aortic valve implantation</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Renal Resistive Index/NephroCheck™test</intervention_name>
    <description>Renal Resistive Index and NephroCheck™ test before TAVI and after TAVI</description>
    <arm_group_label>Renal Resistive Index/NephroCheck™test</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing a TAVI procedure
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients scheduled to undergo a TAVI

        Exclusion Criteria:

          -  Chronic dialysis patients with anuria
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexandre OUATTARA, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>head of anesthesia department II</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Cédrick ZAOUTER, MD, MSc</last_name>
    <phone>33 (0)5 57 65 68 66</phone>
    <email>cedrick.zaouter@chu-bordeaux.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>BORDEAUX UNIVERSITY HOSPITAL - Haut Lévêque</name>
      <address>
        <city>Pessac</city>
        <zip>33604</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cédrick ZAOUTER, MD, MSc</last_name>
      <phone>33 (0)5 57 65 68 66</phone>
      <email>cedrick.zaouter@chu-bordeaux.fr</email>
    </contact>
    <investigator>
      <last_name>Alexandre OUATTARA, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cédrick ZAOUTER, MD, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lionel LEROUX, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Benjamin SEGUY, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 11, 2016</study_first_submitted>
  <study_first_submitted_qc>November 28, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 29, 2016</study_first_posted>
  <last_update_submitted>November 28, 2016</last_update_submitted>
  <last_update_submitted_qc>November 28, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 29, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Transcatheter aortic valve implantation</keyword>
  <keyword>Acute Kidney Injury</keyword>
  <keyword>early acute kidney injury detection</keyword>
  <keyword>Nephrocheck™</keyword>
  <keyword>Renal Resistive Index</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Acute Kidney Injury</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

